The research status and prospect of Periostin in chronic kidney disease

References

• Dussaule JC, Guerrot D, Huby AC, et al. The role of cell plasticity in progression and reversal of renal fibrosis. Int J Exp Pathol. 2011;92(3):151–157.
   PubMed Web of Science ®Google Scholar
• Chatziantoniou C, Dussaule JC. Is kidney injury a reversible process? Curr Opin Nephrol Hypertens. 2008;17(1):76–81.
   PubMed Web of Science ®Google Scholar
• Tang R, Xiao X, Lu Y, et al. Interleukin-22 attenuates renal tubular cells inflammation and fibrosis induced by TGF-β1 through Notch1 signaling pathway. Ren Fail. 2020;42(1):381–390.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Wang JM, Yin H, et al. DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose. Ren Fail. 2020;42(1):463–473.
   PubMed Web of Science ®Google Scholar
• Li X, Bu X, Yan F, et al. Deletion of discoidin domain receptor 2 attenuates renal interstitial fibrosis in a murine unilateral ureteral obstruction model. Ren Fail. 2019;41(1):481–488.
   PubMed Web of Science ®Google Scholar
• Li W, Lu Y, Lou Y, et al. FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis. Ren Fail. 2019;41(1):419–426.
   PubMed Web of Science ®Google Scholar
• Satirapoj B, Tassanasorn S, Charoenpitakchai M, et al. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. PLoS One. 2015;10(4):e124055.
   Web of Science ®Google Scholar
• Guerrot D, Dussaule JC, Mael-Ainin M, et al. Identification of Periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012;7(3):e31974．
   PubMed Web of Science ®Google Scholar
• Takesshita S, Kikuno Tezuka K, et al. Osteoblast－specific factor2:cloning of a putative bone adhesion protein with homology with the insect protein fasciehnI. Biochem J. 1993;294(Pt1):271–278.
   PubMedGoogle Scholar
• Masuoka M, Shiraishi H, Ohta S, et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest. 2012;122(7):2590–2600.
   PubMed Web of Science ®Google Scholar
• Liu AY, Zheng H, Ouyang G. Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments . Matrix Biol. 2014;37(1):150–156.
   PubMedGoogle Scholar
• Mael-Ainin M, Abed A, Conway SJ, et al. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol. 2014;25(8):1724–1736.
   PubMed Web of Science ®Google Scholar
• Litvin J, Zhu S, Norris R, et al. Periostin family of proteins: therapeutic targets for heart disease. Anat Rec A Discov Mol Cell Evol Biol. 2005;287(2):1205–1212.
   PubMedGoogle Scholar
• Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14(7):1239–1249.
   PubMed Web of Science ®Google Scholar
• Lindner V, Wang Q, Conley BA, et al. Vascular injury induces expression of periostin:implications for vascular cell differentiation and migration. ATVB. 2005;25(1):77–83.
   Google Scholar
• Kii I, Nishiyama T, Li M, et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem. 2010;285(3):2028–2039.
   PubMed Web of Science ®Google Scholar
• Litvin J, Selim AH, Montgomery MO, et al. Expression and function of periostin-isoforms in bone . J Cell Biochem. 2004;92(5):1044–1061.
   PubMed Web of Science ®Google Scholar
• Idolazzi L, Ridolo E, Fassio A, et al. Periostin: the bone and beyond . Eur J Intern Med. 2017;38(1):12–16.
   PubMedGoogle Scholar
• Norris RA, Moreno-ROdfiguez RA, Sugi Y, et al. Periostin regulates atrioventricular valve maturation. Dev Biol. 2008;316(2):200–213.
   PubMed Web of Science ®Google Scholar
• Li P, Oparil S, Feng W, et al. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells . J Appl Physiol (1985). 2004;97(4):1550–1558.
   PubMed Web of Science ®Google Scholar
• Bonnet N, Garnero P, Ferrari S. Periostin action in bone. Mol Cell Endocrinol. 2016;432(1):75–82.
   PubMedGoogle Scholar
• Jackson Boeters L, Wen W, Hamilton DW. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair. J Cell Commun Signal. 2009;3(2):125–133.
   PubMed Web of Science ®Google Scholar
• Han T, Mignatti P, Abramson SB, et al. Periostin interaction with discoidin domain eceptor-1 (DDR1) promotes cartilage degeneration. PLoS One. 2020;15(4):e0231501.
   PubMed Web of Science ®Google Scholar
• Ontsuka K, Kotobuki Y, Shiraishi H, et al. Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts . Exp Dermatol. 2012;21(5):331–336.
   PubMed Web of Science ®Google Scholar
• Markwald RR, Norris RA, Moreno Rodriguez R, et al. Developmental basis of adult cardiovascular diseases: valvular heart diseases . Ann N Y Acad Sci. 2010;1188(1):177–183.
   PubMedGoogle Scholar
• Sorocos K, Kostoulias X, Cullen-McEwen L, et al. Expression patterns and roles of Periostin during kidney and ureter development. J Urol. 2011;186(4):1537–1544.
   PubMed Web of Science ®Google Scholar
• Hakuno D, Kimura N, Yoshioka M, et al. Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest. 2010;120(7):2292–2306.
   PubMed Web of Science ®Google Scholar
• Kretzler M, Teixeira VP, Unschuld PG, et al. Integrin-linked kinase as a candidate downstream effector in proteinuria. Faseb J. 2001;15(10):1843–1845.
   PubMedGoogle Scholar
• Wei C, Moller CC, Altintas MM, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med. 2008;14(1):55–63.
   PubMed Web of Science ®Google Scholar
• Kang YS, Li Y, Dai C, et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int. 2010;78(4):363–373.
   PubMed Web of Science ®Google Scholar
• Wallace DP, Quante MT, REif GA, et al. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor. Am J Physiol Renal Physiol. 2008;295(5):F1463–F1471.
   PubMed Web of Science ®Google Scholar
• Inai K, Norris RA, Hoffman S, et al. BMP-2 induces cell migration and Periostin expression during atrioventricular valvulogenesis. Dev Biol. 2008;315(2):383–396.
   PubMed Web of Science ®Google Scholar
• Norris RA, Moreno-Rodriguez R, Hoffman S, et al. The many facets of the matricelluar protein Periostin during cardiac development, remodeling, and pathophysiology . J Cell Commun Signal. 2009;3(3–4):275–286.
   PubMed Web of Science ®Google Scholar
• Oshima A, Tanabe H, Yan T, et al. A novel mechanism for the regulation of osteoblast differentiation: transcription of periostin, a member of the fasciclin I family, is regulated by the bHLH transcription factor, twist . J Cell Biochem. 2002;86(4):792–804.
   PubMed Web of Science ®Google Scholar
• Haertel-Wiesmann M, Liang Y, Fantl WJ, et al. Regulation of cyclooxygenase-2 and Periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem. 2000;275(41):32046–32051.
   PubMed Web of Science ®Google Scholar
• Fortunati D, Reppe S, Fjeldheim AK, et al. Periostin is a collagen associated bone matrix protein regulated by parathyroid hormone. Matrix Biol. 2010;29(7):594–601.
   PubMed Web of Science ®Google Scholar
• Satirapoj B, Witoon R, Ruangkanchanasetr P, et al. Urine Periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc. 2014;46(1):135–140.
   PubMed Web of Science ®Google Scholar
• Wantanasiri P, Satirapoj B, Charoenpitakchai M, et al. Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients. Lupus. 2015;24(8):835–845.
   PubMed Web of Science ®Google Scholar
• Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant. 2012;27(7):2702–2711.
   PubMed Web of Science ®Google Scholar
• Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int. 2008;74(1):22–36.
   PubMed Web of Science ®Google Scholar
• Izuhara K, Arima K, Ohta S, et al. Periostin in allergic inflammation. Allergol Int. 2014;63(2):143–151.
   Web of Science ®Google Scholar
• Kanemitsu Y, Matsumoto H, Izuhara K, et al. Increased Periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol. 2013;132(2):305–312.
   PubMed Web of Science ®Google Scholar
• Ling L, Cheng Y, Ding L, et al. Association of serum Periostin with cardiac function and short-term prognosis in acute myocardial infarction patients. PLoS One. 2014;9(2):e88755.
   PubMed Web of Science ®Google Scholar
• Yamashita O, Yoshimura K, Nagasawa A, et al. Periostin links mechanical strain to inflammation in abdominal aortic aneurysm. PLoS One. 2013;8(11):e79753．
   PubMed Web of Science ®Google Scholar
• Lv Y, Wang W, Jia WD, et al. High preoparative levels of serum Periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Eur J Surg Oncol. 2013;39(10):1129–1135.
   PubMed Web of Science ®Google Scholar
• Nuzzo PV, RUbagotti A, Zinoli L, et al. The prognostic value of stromal and epithelial Periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome. BMC Cancer. 2016;16(1):95.
   PubMedGoogle Scholar
• Xu X, Chang W, Yuan J, et al. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche. Oncotarget. 2016;7(1):798–813.
   PubMedGoogle Scholar
• Nuzzo PV, Rubagotti A, Zinoli L, et al. Prognostic value of stromal and epithelial Periostin expression in human prostate cancer:correlation with clinical pathological features and the risk of biochemical relapse or death. BMC Cancer. 2012;12(1):625.
   PubMedGoogle Scholar
• Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179(4):1756–1767.
   PubMed Web of Science ®Google Scholar
• Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications. 1998;12(1):43–60.
   PubMed Web of Science ®Google Scholar
• W Allace DP, Quante MT, Reif GA, et al. Periostin induces proliferation of human autosomal dominant polyeystic kidney cells through alphaVintegrin receptor. Am J Physiol Renal Physiol. 2008;295(5):1463–1471.
   Google Scholar
• Li G, Oparil S, Sanders JM, et al. Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis. 2006;188(2):292–300.
   PubMed Web of Science ®Google Scholar
• Reidy K, Susztak K. Epithelial - mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis. 2009;54(4):590–593.
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN. Mediators of diabetic renal disease: the case for tgfBeta as the major mediator. J Am Soc Nephrol. 2004; 15(Suppl 1):S55–S57.
   PubMed Web of Science ®Google Scholar
• Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-beta in renal disease. Kidney Blood Press Res. 1998;21(1):1–12.
   PubMed Web of Science ®Google Scholar
• Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31(1):68–74.
   PubMed Web of Science ®Google Scholar
• Meng X-M, Tang PM-K, Li J, et al. TGF-β/Smad signaling in renal fibrosis. Front Physiol. 2015;6:82.
   PubMed Web of Science ®Google Scholar